
The Laboratory of Systems Pharmacology at Harvard Medical School advances drug discovery and development through interdisciplinary collaboration. It combines clinical insight, biomedical research, and software engineering to tackle how diseases arise and how drugs work in the body, using machine learning and AI to identify targets and predict therapeutic and adverse effects. The group studies clinical trial design and interpretation to improve patient outcomes across diseases such as cancer, Alzheimer's, and infectious diseases. It operates within the Harvard Program in Therapeutic Science, applying computational modeling, genomics, and other data-driven methods to accelerate translational science.

The Laboratory of Systems Pharmacology at Harvard Medical School advances drug discovery and development through interdisciplinary collaboration. It combines clinical insight, biomedical research, and software engineering to tackle how diseases arise and how drugs work in the body, using machine learning and AI to identify targets and predict therapeutic and adverse effects. The group studies clinical trial design and interpretation to improve patient outcomes across diseases such as cancer, Alzheimer's, and infectious diseases. It operates within the Harvard Program in Therapeutic Science, applying computational modeling, genomics, and other data-driven methods to accelerate translational science.